BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 22491032)

  • 1. Enhancers: emerging roles in cell fate specification.
    Ong CT; Corces VG
    EMBO Rep; 2012 Apr; 13(5):423-30. PubMed ID: 22491032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
    Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
    FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.
    Sérandour AA; Avner S; Percevault F; Demay F; Bizot M; Lucchetti-Miganeh C; Barloy-Hubler F; Brown M; Lupien M; Métivier R; Salbert G; Eeckhoute J
    Genome Res; 2011 Apr; 21(4):555-65. PubMed ID: 21233399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromatin signatures of enhancers and their dynamic regulation.
    Barral A; Déjardin J
    Nucleus; 2023 Dec; 14(1):2160551. PubMed ID: 36602897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique chromatin signature uncovers early developmental enhancers in humans.
    Rada-Iglesias A; Bajpai R; Swigut T; Brugmann SA; Flynn RA; Wysocka J
    Nature; 2011 Feb; 470(7333):279-83. PubMed ID: 21160473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
    Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate Promoter and Enhancer Identification in 127 ENCODE and Roadmap Epigenomics Cell Types and Tissues by GenoSTAN.
    Zacher B; Michel M; Schwalb B; Cramer P; Tresch A; Gagneur J
    PLoS One; 2017; 12(1):e0169249. PubMed ID: 28056037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer RNA: biogenesis, function, and regulation.
    Ye R; Cao C; Xue Y
    Essays Biochem; 2020 Dec; 64(6):883-894. PubMed ID: 33034351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin signatures of active enhancers.
    Spicuglia S; Vanhille L
    Nucleus; 2012 Mar; 3(2):126-31. PubMed ID: 22555596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional transcription initiation marks accessible chromatin and is not specific to enhancers.
    Young RS; Kumar Y; Bickmore WA; Taylor MS
    Genome Biol; 2017 Dec; 18(1):242. PubMed ID: 29284524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H3K27ac separates active from poised enhancers and predicts developmental state.
    Creyghton MP; Cheng AW; Welstead GG; Kooistra T; Carey BW; Steine EJ; Hanna J; Lodato MA; Frampton GM; Sharp PA; Boyer LA; Young RA; Jaenisch R
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21931-6. PubMed ID: 21106759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chromatin dynamics in immune cell development.
    Winter DR; Amit I
    Immunol Rev; 2014 Sep; 261(1):9-22. PubMed ID: 25123274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic enhancers: common features, regulation, and participation in diseases.
    Erokhin M; Vassetzky Y; Georgiev P; Chetverina D
    Cell Mol Life Sci; 2015 Jun; 72(12):2361-75. PubMed ID: 25715743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of enhancer chromatin: what, how, and why?
    Calo E; Wysocka J
    Mol Cell; 2013 Mar; 49(5):825-37. PubMed ID: 23473601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation.
    González AJ; Setty M; Leslie CS
    Nat Genet; 2015 Nov; 47(11):1249-59. PubMed ID: 26390058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of Muscle- and Brain-Specific Expression of KLHL Family Genes.
    Ehrlich KC; Baribault C; Ehrlich M
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182325
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancer function: new insights into the regulation of tissue-specific gene expression.
    Ong CT; Corces VG
    Nat Rev Genet; 2011 Apr; 12(4):283-93. PubMed ID: 21358745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Enhancing' red cell fate through epigenetic mechanisms.
    Rossmann MP; Zon LI
    Curr Opin Hematol; 2021 May; 28(3):129-137. PubMed ID: 33741760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation patterns expose variations in enhancer-chromatin modifications during embryonic stem cell differentiation.
    Alajem A; Roth H; Ratgauzer S; Bavli D; Motzik A; Lahav S; Peled I; Ram O
    PLoS Genet; 2021 Apr; 17(4):e1009498. PubMed ID: 33844685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.